In the context of recent compliance and enforcement trends, this forum will ask and answer such questions as: Should FDA and other government agencies place more of a priority on criminal enforcement? How has the Park doctrine and the Responsible Corporate Officer doctrine evolved, and is this good public policy? What is the significance of recent False Claims and Whistleblower lawsuits? What is the significance of the Foreign Corrupt Practices Act on our global industry? And, what can we learn from past government actions, and how should what we learn impact our future practices?